Microbiology

  1. Structure, receptor recognition, and antigenicity of the human coronavirus CCoV-HuPn-2018 spike glycoprotein

    1. M. Alejandra Tortorici
    2. Alexandra C. Walls
    3. Anshu Joshi
    4. Young-Jun Park
    5. Rachel T. Eguia
    6. Marcos C. Miranda
    7. Elizabeth Kepl
    8. Annie Dosey
    9. Terry Stevens-Ayers
    10. Michael J. Boeckh
    11. Amalio Telenti
    12. Antonio Lanzavecchia
    13. Neil P. King
    14. Davide Corti
    15. Jesse D. Bloom
    16. David Veesler

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. Reduced replication but increased interferon resistance of SARS-CoV-2 Omicron BA.1

    1. Rayhane Nchioua
    2. Annika Schundner
    3. Susanne Klute
    4. Lennart Koepke
    5. Maximilian Hirschenberger
    6. Sabrina Noettger
    7. Giorgio Fois
    8. Fabian Zech
    9. Alexander Graf
    10. Stefan Krebs
    11. Peter Braubach
    12. Helmut Blum
    13. Steffen Stenger
    14. Dorota Kmiec
    15. Manfred Frick
    16. Frank Kirchhoff
    17. Konstantin MJ Sparrer

    Reviewed by ScreenIT

    1 evaluationAppears in 2 listsLatest version Latest activity

  3. Multiple spillovers from humans and onward transmission of SARS-CoV-2 in white-tailed deer

    1. Suresh V. Kuchipudi
    2. Meera Surendran-Nair
    3. Rachel M. Ruden
    4. Michele Yon
    5. Ruth H. Nissly
    6. Kurt J. Vandegrift
    7. Rahul K. Nelli
    8. Lingling Li
    9. Bhushan M. Jayarao
    10. Costas D. Maranas
    11. Nicole Levine
    12. Katriina Willgert
    13. Andrew J. K. Conlan
    14. Randall J. Olsen
    15. James J. Davis
    16. James M. Musser
    17. Peter J. Hudson
    18. Vivek Kapur

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. Antiviral activity of pacific oyster ( Crassostrea gigas ) hemolymph against a human coronavirus

    1. Rebecca L. Pedler
    2. James O. Harris
    3. Peter G. Speck

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Glycosylated extracellular mucin domains protect against SARS-CoV-2 infection at the respiratory surface

    1. Maitrayee Chatterjee
    2. Liane Z. X. Huang
    3. Anna Z. Mykytyn
    4. Chunyan Wang
    5. Mart M. Lamers
    6. Bart Westendorp
    7. Richard W. Wubbolts
    8. Jos P. M. van Putten
    9. Berend-Jan Bosch
    10. Bart L. Haagmans
    11. Karin Strijbis

    Reviewed by Rapid Reviews Infectious Diseases, ScreenIT

    5 evaluationsAppears in 2 listsLatest version Latest activity

  6. Efficacy of anti-microbial gel vapours against aerosolised coronavirus, bacteria, and fungi

    1. Parthasarathi Kalaiselvan
    2. Muhammad Yasir
    3. Mark Willcox
    4. Ajay Kumar Vijay

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. The oral protease inhibitor (PF-07321332) protects Syrian hamsters against infection with SARS-CoV-2 variants of concern

    1. Rana Abdelnabi
    2. Caroline S. Foo
    3. Dirk Jochmans
    4. Laura Vangeel
    5. Steven De Jonghe
    6. Patrick Augustijns
    7. Raf Mols
    8. Birgit Weynand
    9. Thanaporn Wattanakul
    10. Richard M. Hoglund
    11. Joel Tarning
    12. Charles E. Mowbray
    13. Peter Sjö
    14. Fanny Escudié
    15. Ivan Scandale
    16. Eric Chatelain
    17. Johan Neyts

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. SARS-CoV-2 variants of concern remain dependent on IFITM2 for efficient replication in human lung cells

    1. Rayhane Nchioua
    2. Annika Schundner
    3. Dorota Kmiec
    4. Caterina Prelli-Bozzo
    5. Fabian Zech
    6. Lennart Koepke
    7. Alexander Graf
    8. Stefan Krebs
    9. Helmut Blum
    10. Manfred Frick
    11. Konstantin M. J. Sparrer
    12. Frank Kirchhoff

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. Clinically observed deletions in SARS‐CoV‐2 Nsp1 affect its stability and ability to inhibit translation

    1. Pravin Kumar
    2. Erin Schexnaydre
    3. Karim Rafie
    4. Tatsuaki Kurata
    5. Ilya Terenin
    6. Vasili Hauryliuk
    7. Lars‐Anders Carlson

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Stenoparib, an inhibitor of cellular poly (ADP-ribose) polymerases (PARPs), blocks in vitro replication of SARS-CoV-2 variants

    1. Katherine E. Zarn
    2. Sierra A. Jaramillo
    3. Anthony R. Zapata
    4. Nathan E. Stone
    5. Ashley N. Jones
    6. Haley E. Nunnally
    7. Erik W. Settles
    8. Ken Ng
    9. Paul S. Keim
    10. Steen Knudsen
    11. Patricia M. Nuijten
    12. Aloys S. L. Tijsma
    13. Christopher T. French

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 131 of 252 Next